Infliximab improves serum adiponectin levels and endothelial dysfunction in patients with rheumatoid arthritis.

被引：0
|
作者：
Sakuta, T
Komai, N
Haruna, Y
Kuwabara, A
Horike, H
Kashihara, N
Fox, DA
Morita, Y
机构：
[1] Kawasaki Med Sch, Kurashiki, Okayama, Japan
[2] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S543 / S544
页数：2
相关论文
共 50 条
  • [31] SERUM LEPTIN AND ADIPONECTIN LEVELS IN RHEUMATOID ARTHRITIS PATIENTS, THEIR ASSOCIATION WITH INFLAMMATORY PROCESS
    Galiutina, O.
    Shevchuk, S.
    Seheda, Y.
    Kuvikova, I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1257 - 1258
  • [32] Infliximab improves vascular stiffness in patients with rheumatoid arthritis
    Wong, M.
    Oakley, S. P.
    Young, L.
    Jiang, B. Y.
    Wierzbicki, A.
    Panayi, G.
    Chowienczyk, P.
    Kirkham, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (08) : 1277 - 1284
  • [33] Endothelial Dysfunction Improves in Patients with Rheumatoid Arthritis by Reducing Disease Activity.
    de Groot, Lodewijk
    Westra, Johanna
    Jager, Nynke
    Posthumus, Marcel D.
    Bijl, Marc
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S451 - S451
  • [34] Body composition and serum levels of adiponectin, vascular endothelial growth factor, and interleukin-6 in patients with rheumatoid arthritis
    Oranskiy, Sergey P.
    Yeliseyeva, Ludmila N.
    Tsanaeva, Anna V.
    Zaytseva, Nadezhda V.
    [J]. CROATIAN MEDICAL JOURNAL, 2012, 53 (04) : 350 - 356
  • [35] Endothelial dysfunction and laboratory markers of inflammation and accelerated atherosclerosis in rheumatoid arthritis.
    Szekanecz, Zoltán
    Kerekes, György
    Dér, Henriette
    Sándor, Zsuzsa
    Muszbek, László
    Csipö, István
    Sipka, Sándor
    Seres, Ildikó
    Paragh, György
    Szomják, Edit
    Veres, Katalin
    Shoenfeld, Yehuda
    Szegedi, Gyula
    Soltész, Pál
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S362 - S363
  • [36] Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritis
    Derdemezis, Christos S.
    Filippatos, Theodosios D.
    Voulgari, Paraskevi V.
    Tselepis, Alexandros D.
    Drosos, Alexandros A.
    Kiortsis, Dimitrios N.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 (05) : 595 - 600
  • [37] A difference in effectiveness between infliximab, etanercept and adalimumab in patients with rheumatoid arthritis.
    Kievit, Wietske
    Fransen, Jaap
    Kuper, Ina H.
    van de Laar, Mart A. F. J.
    Jansen, Tim L.
    De Rooij, Dirk jan R. A. M.
    de Gendt, Carla M.
    Ronday, Karel H.
    Brus, Herman L. M.
    van Ooijen, Piet C. M.
    van Riel, Piet C. L. M.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S309 - S310
  • [38] Altered Serum Levels of Bone Metabolism Markers in Rheumatoid Arthritis.
    Zhu, Lang Jing
    Ouyang, Xia
    Dai, Lie
    Zheng, Dong Hui
    Mo, Ying Qian
    Wei, Xiu Ning
    Zou, Chan Juan
    Zhang, Bai Yu
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S894 - S895
  • [39] Infliximab in rheumatoid arthritis. Why do patients warrant dose increases?
    Haraoui, P
    Cameron, L
    Ouellet, M
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 298 - 298
  • [40] Positive effects of infliximab therapy on bone metabolism in patients with rheumatoid arthritis.
    Thomas, T
    Garnero, P
    le Henanff, A
    Debiais, F
    Le Loet, X
    Roux, C
    Sany, J
    Wendling, D
    Zarnitsky, C
    Ravaux, P
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S333 - S333
12345